Research Institute: Centre for Cancer Biology
Amount granted: $2 million
Year granted: 2015
The ACRF Cancer Discovery Accelerator facility in Adelaide will house cutting-edge technologies currently unavailable in Australia, and will greatly expand the research expertise and capabilities in South Australia and across the continent.
The new technologies include the latest genome sequencing equipment and a super high resolution microscope, enabling researchers to develop powerful new methods for measuring proteins in individual cancer cells. The availability of the technologies within a single integrated facility will enhance technology uptake and ensure optimal application of these methodologies for the ultimate benefit of the end users – cancer patients.
The ACRF Cancer Discovery Accelerator will be housed in UniSA’s new Health Innovation Building currently being constructed on North Terrace.
Image CC BY-SA 2.0
What your donations have achieved
Cervical cancer vaccine
We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.
The pill that melts away cancer
Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialled for other types of cancer.
Personalised cancer diagnosis
In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.
Zero childhood cancer
We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.